NOVA MSC BERHAD
01 Oct 2018
The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the earlier announcements in relation to the Proposed Investment.
We refer to our earlier announcements dated 17 August 2018 in relation to the Proposed Investment.
The Board of Directors of NOVAMSC wishes to announce that 41,999 new Eyris Shares has been issued and allotted to novaHEALTH resulting in Eyris being a 42%-owned indirect subsidiary of NOVAMSC.
This announcement is dated 1 October 2018